Atlas Trials

Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder

Clinical trial NCT01981811 · WITHDRAWN

Trial details

NCT number
NCT01981811
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Bipolar 1 DisorderSchizophreniaMental DisorderNervous System Diseases
Start date
2014-03-01
Primary completion
2014-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.